This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimers disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention. The book discusses how computer-aided drug design approaches reduce costs and increase biological test efficiency. It reviews the screening for anti-Alzheimer drugs and biomarker analysis of disease inhibitors. The book also explores mechanistic aspects of neurodegeneration and the use of natural products as therapeutics for Alzheimers disease.
Key features:
- Elaborates on the computational modelling of protein target inhibitors as anti-Alzheimers agents
- Explains the role of phytomolecules and natural products in Alzheimers therapy
- Reviews preclinical ways to assess drugs focusing on Alzheimers disease
- Covers biomarker analysis for Alzheimers disease
- Discusses the onset and progression of Alzheimers disease
The book is meant for professionals, researchers, and students of neuroscience, psychology, and computational neurosciences.
